Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Neurology and therapy
| Neurology and therapy |
| Pubbl/distr/stampa | New York : , : Springer Healthcare, , 2012- |
| Descrizione fisica | 1 online resource |
| Disciplina | 616.806 |
| Soggetto topico |
Neurology - Treatment
Neurology Neurologie - Traitement Neurologie Nervous System Diseases - therapy |
| Soggetto genere / forma |
Periodicals.
Periodical |
| ISSN | 2193-6536 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti |
Neurology & therapy
Neurol Ther |
| Record Nr. | UNINA-9910141432403321 |
| New York : , : Springer Healthcare, , 2012- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Neurology and therapy
| Neurology and therapy |
| Pubbl/distr/stampa | New York : , : Springer Healthcare, , 2012- |
| Descrizione fisica | 1 online resource |
| Disciplina | 616.806 |
| Soggetto topico |
Neurology - Treatment
Neurology Neurologie - Traitement Neurologie Nervous System Diseases - therapy |
| Soggetto genere / forma |
Periodicals.
Periodical |
| ISSN | 2193-6536 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti |
Neurology & therapy
Neurol Ther |
| Record Nr. | UNISA-996214839203316 |
| New York : , : Springer Healthcare, , 2012- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Neuromodulation [[electronic resource] /] / edited by Elliot S. Krames, P. Hunter Peckham, Ali R. Rezai
| Neuromodulation [[electronic resource] /] / edited by Elliot S. Krames, P. Hunter Peckham, Ali R. Rezai |
| Pubbl/distr/stampa | London ; ; Burlington, MA, : Academic Press, 2009 |
| Descrizione fisica | 1 online resource (xxiii, 1063 pages) : illustrations |
| Disciplina | 616.806 |
| Altri autori (Persone) |
KramesElliot
PeckhamP. Hunter RezaiAli R |
| Soggetto topico |
Central nervous system - Physiology
Neural transmission - Regulation |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-282-16862-2
9786612168628 0-08-092139-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
v. 1. Section I. An introduction to neuromodulation -- Section II. Fundamentals of neuromodulation -- Section IIA. Fundamentals of neuromodulation: mechanisms -- Section III. Biomedical engineering considerations -- Section IV. Neuromodulation for chronic pain -- Section IVA. Periphery and spinal cord electrical stimulation for non-visceral pain -- Section IVB. Infusional therapies for pain -- Section IVC. Brain stimulation for pain.
v. 2. Section V. Neuomodulation for movement disorders -- Section VI. Neurostimulation for epilepsy -- Section VII. Neuromodulation for psychiatrc disorders -- Section VIII. Neuromodulation for functional restoration -- Section IX. Neuromodulation of body organs -- Section IXA. Neuromodulation for cardiovascular disorders -- Section IXB. Neuromodulation for gastrointestinal disorders -- Section IXC. Neuromodulation for urogenital disorders -- Section X. Neuromodulation for emerging applications -- Section XI. Neuromodulation device implant techniques. |
| Record Nr. | UNINA-9910455269803321 |
| London ; ; Burlington, MA, : Academic Press, 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Neuromodulation [[electronic resource] /] / edited by Elliot S. Krames, P. Hunter Peckham, Ali R. Rezai
| Neuromodulation [[electronic resource] /] / edited by Elliot S. Krames, P. Hunter Peckham, Ali R. Rezai |
| Pubbl/distr/stampa | London ; ; Burlington, MA, : Academic Press, 2009 |
| Descrizione fisica | 1 online resource (xxiii, 1063 pages) : illustrations |
| Disciplina | 616.806 |
| Altri autori (Persone) |
KramesElliot
PeckhamP. Hunter RezaiAli R |
| Soggetto topico |
Central nervous system - Physiology
Neural transmission - Regulation |
| ISBN |
1-282-16862-2
9786612168628 0-08-092139-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
v. 1. Section I. An introduction to neuromodulation -- Section II. Fundamentals of neuromodulation -- Section IIA. Fundamentals of neuromodulation: mechanisms -- Section III. Biomedical engineering considerations -- Section IV. Neuromodulation for chronic pain -- Section IVA. Periphery and spinal cord electrical stimulation for non-visceral pain -- Section IVB. Infusional therapies for pain -- Section IVC. Brain stimulation for pain.
v. 2. Section V. Neuomodulation for movement disorders -- Section VI. Neurostimulation for epilepsy -- Section VII. Neuromodulation for psychiatrc disorders -- Section VIII. Neuromodulation for functional restoration -- Section IX. Neuromodulation of body organs -- Section IXA. Neuromodulation for cardiovascular disorders -- Section IXB. Neuromodulation for gastrointestinal disorders -- Section IXC. Neuromodulation for urogenital disorders -- Section X. Neuromodulation for emerging applications -- Section XI. Neuromodulation device implant techniques. |
| Record Nr. | UNINA-9910777943503321 |
| London ; ; Burlington, MA, : Academic Press, 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Neuromodulation / / edited by Elliot S. Krames, P. Hunter Peckham, Ali R. Rezai
| Neuromodulation / / edited by Elliot S. Krames, P. Hunter Peckham, Ali R. Rezai |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | London ; ; Burlington, MA, : Academic Press, 2009 |
| Descrizione fisica | 1 online resource (xxiii, 1063 pages) : illustrations |
| Disciplina | 616.806 |
| Altri autori (Persone) |
KramesElliot
PeckhamP. Hunter RezaiAli R |
| Soggetto topico |
Central nervous system - Physiology
Neural transmission - Regulation |
| ISBN |
1-282-16862-2
9786612168628 0-08-092139-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
v. 1. Section I. An introduction to neuromodulation -- Section II. Fundamentals of neuromodulation -- Section IIA. Fundamentals of neuromodulation: mechanisms -- Section III. Biomedical engineering considerations -- Section IV. Neuromodulation for chronic pain -- Section IVA. Periphery and spinal cord electrical stimulation for non-visceral pain -- Section IVB. Infusional therapies for pain -- Section IVC. Brain stimulation for pain.
v. 2. Section V. Neuomodulation for movement disorders -- Section VI. Neurostimulation for epilepsy -- Section VII. Neuromodulation for psychiatrc disorders -- Section VIII. Neuromodulation for functional restoration -- Section IX. Neuromodulation of body organs -- Section IXA. Neuromodulation for cardiovascular disorders -- Section IXB. Neuromodulation for gastrointestinal disorders -- Section IXC. Neuromodulation for urogenital disorders -- Section X. Neuromodulation for emerging applications -- Section XI. Neuromodulation device implant techniques. |
| Record Nr. | UNINA-9910808719603321 |
| London ; ; Burlington, MA, : Academic Press, 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Neuroprotection [[electronic resource] ] : models, mechanisms and therapies / / edited by Mathias Bähr
| Neuroprotection [[electronic resource] ] : models, mechanisms and therapies / / edited by Mathias Bähr |
| Pubbl/distr/stampa | Weinheim, : Wiley-VCH, c2004 |
| Descrizione fisica | 1 online resource (391 p.) |
| Disciplina | 616.806 |
| Altri autori (Persone) | BährMathias |
| Soggetto topico |
Nervous system - Diseases - Treatment
Molecular neurobiology |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-51966-5
9786610519668 3-527-60386-7 3-527-60431-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Neuroprotection Models, Mechanismsand Therapies; Preface; Contents; List of Contributors; I Neurological Disorders - Epidemiology, Clinical Overview, and Model Systems; 1 Stroke; Abstract; 1.1 Introduction; 1.2 The Penumbra Concept; 1.3 Excitotoxicity; 1.4 Oxygen Free Radicals; 1.5 Tissue Acidosis; 1.6 Peri-infarct Depolarizations; 1.7 Inflammation; 1.8 Damage to the Blood-Brain-Barrier; 1.9 Programmed Cell Death and Apoptosis; 1.10 Ischemia-induced DNA Damage, DNA Repair, and p53 as Genotoxic Sensor; 1.11 Epigenetics; 1.12 Gene Expression; 1.13 Cell Replacement
1.14 Endogenous Neuroprotection - Ischemic Tolerance1.15 Stroke Induced Immune Depression (SIDS); 1.16 Conclusion; References; 2 Parkinson's Disease; 2.1 Epidemiology of Parkinson's Disease; 2.1.1 Genetic Contribution; 2.1.2 Environmental Factors; 2.2 Oxidative Stress In Parkinson's Disease; 2.3 Role of Alpha-Synuclein in Parkinson's Disease; 2.3.1 Alpha-Synuclein in Lewy Bodies; 2.3.2 Alpha-Synuclein and Oxidative Stress; 2.4 The Involvement of Proteosome in PD; 2.4.1 Parkin Involvement in PD; 2.5 Other Genes Involved in Familial Parkinson's Disease; 2.6 Neurotoxic PD Models 2.6.1 Oxidative Stress2.6.2 Dopamine Homeostasis/Complex I; 2.6.3 Proteasome; 2.7 Genetic Models of Parkinson's Disease; 2.7.1 Alpha-Synuclein Overexpressing Transgenic Animals; 2.7.2 Parkin-related Genetic Models; 2.7.3 Viral Vectors for In Vivo Gene Transfer of Disease-related Proteins to the CNS; 2.7.3.1 Local Overexpression of alpha-synuclein; 2.7.3.2 Local Overexpression of Parkin-related Proteins; Acknowledgements; References; 3 Amyotrophic Lateral Sclerosis; 3.1 Human Motor Neuron Diseases; 3.1.1 Familial ALS Linked to SOD1 Mutations; 3.1.2 Juvenile ALS Linked to Alsin Mutations 3.2 Cell Culture Models of Motoneuron Degeneration3.2.1 Neuronal Cell Lines; 3.2.2 Isolated Motoneuron Cultures; 3.2.3 Organotypic Cultures; 3.3 Animal Models of Motor Neuron Disease; 3.3.1 Axotomy Models; 3.2 Mutant SOD1 Mice; 3.3.3 pmn Mice; 3.4 Future Neuroprotective Approaches; 3.4.1 Axonal Protection; 3.4.2 Mutant SOD1 Knockdown by RNA Interference; 3.5 Conclusion; References; 4 Alzheimer's Disease and Other Neurodegenerative Diseases; Abstract; 4.1 Introduction; 4.2 Transgenic Invertebrates; 4.3 Transgenic Mice; 4.3.1 Tyrosine Hydroxylase (TH) Promoter 4.3.2 Platelet-derived Growth Factor-β (PDGFβ) Promoter4.3.3 Thy1 Promoter; 4.3.4 Prion Protein (PrP) Promoter; 4.3.5 Glial Expression; 4.4 Viral Models; 4.5 Conclusion and Outlook; References; 5 CNS Inflammation; 5.1 Introduction; 5.2 The Pathologic Characteristics of the MS Plaque; 5.3 Axonal Pathology in MS; 5.4 Neuronal Pathology in Multiple Sclerosis; 5.5 Lessons from Animal Models; References; 6 Neurotrauma; 6.1 Introduction; 6.2 In Vivo Models; 6.2.1 Static Brain Injury Models; 6.2.2 Dynamic Brain Injury Models; 6.2.2.1 Indirect Dynamic Brain Injury; 6.2.2.2 Direct Dynamic Brain Injury 6.2.3 Combined Neurotrauma Models |
| Record Nr. | UNINA-9910144731603321 |
| Weinheim, : Wiley-VCH, c2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Neuroprotection [[electronic resource] ] : models, mechanisms and therapies / / edited by Mathias Bähr
| Neuroprotection [[electronic resource] ] : models, mechanisms and therapies / / edited by Mathias Bähr |
| Pubbl/distr/stampa | Weinheim, : Wiley-VCH, c2004 |
| Descrizione fisica | 1 online resource (391 p.) |
| Disciplina | 616.806 |
| Altri autori (Persone) | BährMathias |
| Soggetto topico |
Nervous system - Diseases - Treatment
Molecular neurobiology |
| ISBN |
1-280-51966-5
9786610519668 3-527-60386-7 3-527-60431-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Neuroprotection Models, Mechanismsand Therapies; Preface; Contents; List of Contributors; I Neurological Disorders - Epidemiology, Clinical Overview, and Model Systems; 1 Stroke; Abstract; 1.1 Introduction; 1.2 The Penumbra Concept; 1.3 Excitotoxicity; 1.4 Oxygen Free Radicals; 1.5 Tissue Acidosis; 1.6 Peri-infarct Depolarizations; 1.7 Inflammation; 1.8 Damage to the Blood-Brain-Barrier; 1.9 Programmed Cell Death and Apoptosis; 1.10 Ischemia-induced DNA Damage, DNA Repair, and p53 as Genotoxic Sensor; 1.11 Epigenetics; 1.12 Gene Expression; 1.13 Cell Replacement
1.14 Endogenous Neuroprotection - Ischemic Tolerance1.15 Stroke Induced Immune Depression (SIDS); 1.16 Conclusion; References; 2 Parkinson's Disease; 2.1 Epidemiology of Parkinson's Disease; 2.1.1 Genetic Contribution; 2.1.2 Environmental Factors; 2.2 Oxidative Stress In Parkinson's Disease; 2.3 Role of Alpha-Synuclein in Parkinson's Disease; 2.3.1 Alpha-Synuclein in Lewy Bodies; 2.3.2 Alpha-Synuclein and Oxidative Stress; 2.4 The Involvement of Proteosome in PD; 2.4.1 Parkin Involvement in PD; 2.5 Other Genes Involved in Familial Parkinson's Disease; 2.6 Neurotoxic PD Models 2.6.1 Oxidative Stress2.6.2 Dopamine Homeostasis/Complex I; 2.6.3 Proteasome; 2.7 Genetic Models of Parkinson's Disease; 2.7.1 Alpha-Synuclein Overexpressing Transgenic Animals; 2.7.2 Parkin-related Genetic Models; 2.7.3 Viral Vectors for In Vivo Gene Transfer of Disease-related Proteins to the CNS; 2.7.3.1 Local Overexpression of alpha-synuclein; 2.7.3.2 Local Overexpression of Parkin-related Proteins; Acknowledgements; References; 3 Amyotrophic Lateral Sclerosis; 3.1 Human Motor Neuron Diseases; 3.1.1 Familial ALS Linked to SOD1 Mutations; 3.1.2 Juvenile ALS Linked to Alsin Mutations 3.2 Cell Culture Models of Motoneuron Degeneration3.2.1 Neuronal Cell Lines; 3.2.2 Isolated Motoneuron Cultures; 3.2.3 Organotypic Cultures; 3.3 Animal Models of Motor Neuron Disease; 3.3.1 Axotomy Models; 3.2 Mutant SOD1 Mice; 3.3.3 pmn Mice; 3.4 Future Neuroprotective Approaches; 3.4.1 Axonal Protection; 3.4.2 Mutant SOD1 Knockdown by RNA Interference; 3.5 Conclusion; References; 4 Alzheimer's Disease and Other Neurodegenerative Diseases; Abstract; 4.1 Introduction; 4.2 Transgenic Invertebrates; 4.3 Transgenic Mice; 4.3.1 Tyrosine Hydroxylase (TH) Promoter 4.3.2 Platelet-derived Growth Factor-β (PDGFβ) Promoter4.3.3 Thy1 Promoter; 4.3.4 Prion Protein (PrP) Promoter; 4.3.5 Glial Expression; 4.4 Viral Models; 4.5 Conclusion and Outlook; References; 5 CNS Inflammation; 5.1 Introduction; 5.2 The Pathologic Characteristics of the MS Plaque; 5.3 Axonal Pathology in MS; 5.4 Neuronal Pathology in Multiple Sclerosis; 5.5 Lessons from Animal Models; References; 6 Neurotrauma; 6.1 Introduction; 6.2 In Vivo Models; 6.2.1 Static Brain Injury Models; 6.2.2 Dynamic Brain Injury Models; 6.2.2.1 Indirect Dynamic Brain Injury; 6.2.2.2 Direct Dynamic Brain Injury 6.2.3 Combined Neurotrauma Models |
| Record Nr. | UNINA-9910830908803321 |
| Weinheim, : Wiley-VCH, c2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Neuroprotection : models, mechanisms and therapies / / edited by Mathias Bahr
| Neuroprotection : models, mechanisms and therapies / / edited by Mathias Bahr |
| Pubbl/distr/stampa | Weinheim, : Wiley-VCH, c2004 |
| Descrizione fisica | 1 online resource (391 p.) |
| Disciplina | 616.806 |
| Altri autori (Persone) | BahrMathias |
| Soggetto topico |
Nervous system - Diseases - Treatment
Molecular neurobiology |
| ISBN |
1-280-51966-5
9786610519668 3-527-60386-7 3-527-60431-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Neuroprotection Models, Mechanismsand Therapies; Preface; Contents; List of Contributors; I Neurological Disorders - Epidemiology, Clinical Overview, and Model Systems; 1 Stroke; Abstract; 1.1 Introduction; 1.2 The Penumbra Concept; 1.3 Excitotoxicity; 1.4 Oxygen Free Radicals; 1.5 Tissue Acidosis; 1.6 Peri-infarct Depolarizations; 1.7 Inflammation; 1.8 Damage to the Blood-Brain-Barrier; 1.9 Programmed Cell Death and Apoptosis; 1.10 Ischemia-induced DNA Damage, DNA Repair, and p53 as Genotoxic Sensor; 1.11 Epigenetics; 1.12 Gene Expression; 1.13 Cell Replacement
1.14 Endogenous Neuroprotection - Ischemic Tolerance1.15 Stroke Induced Immune Depression (SIDS); 1.16 Conclusion; References; 2 Parkinson's Disease; 2.1 Epidemiology of Parkinson's Disease; 2.1.1 Genetic Contribution; 2.1.2 Environmental Factors; 2.2 Oxidative Stress In Parkinson's Disease; 2.3 Role of Alpha-Synuclein in Parkinson's Disease; 2.3.1 Alpha-Synuclein in Lewy Bodies; 2.3.2 Alpha-Synuclein and Oxidative Stress; 2.4 The Involvement of Proteosome in PD; 2.4.1 Parkin Involvement in PD; 2.5 Other Genes Involved in Familial Parkinson's Disease; 2.6 Neurotoxic PD Models 2.6.1 Oxidative Stress2.6.2 Dopamine Homeostasis/Complex I; 2.6.3 Proteasome; 2.7 Genetic Models of Parkinson's Disease; 2.7.1 Alpha-Synuclein Overexpressing Transgenic Animals; 2.7.2 Parkin-related Genetic Models; 2.7.3 Viral Vectors for In Vivo Gene Transfer of Disease-related Proteins to the CNS; 2.7.3.1 Local Overexpression of alpha-synuclein; 2.7.3.2 Local Overexpression of Parkin-related Proteins; Acknowledgements; References; 3 Amyotrophic Lateral Sclerosis; 3.1 Human Motor Neuron Diseases; 3.1.1 Familial ALS Linked to SOD1 Mutations; 3.1.2 Juvenile ALS Linked to Alsin Mutations 3.2 Cell Culture Models of Motoneuron Degeneration3.2.1 Neuronal Cell Lines; 3.2.2 Isolated Motoneuron Cultures; 3.2.3 Organotypic Cultures; 3.3 Animal Models of Motor Neuron Disease; 3.3.1 Axotomy Models; 3.2 Mutant SOD1 Mice; 3.3.3 pmn Mice; 3.4 Future Neuroprotective Approaches; 3.4.1 Axonal Protection; 3.4.2 Mutant SOD1 Knockdown by RNA Interference; 3.5 Conclusion; References; 4 Alzheimer's Disease and Other Neurodegenerative Diseases; Abstract; 4.1 Introduction; 4.2 Transgenic Invertebrates; 4.3 Transgenic Mice; 4.3.1 Tyrosine Hydroxylase (TH) Promoter 4.3.2 Platelet-derived Growth Factor-β (PDGFβ) Promoter4.3.3 Thy1 Promoter; 4.3.4 Prion Protein (PrP) Promoter; 4.3.5 Glial Expression; 4.4 Viral Models; 4.5 Conclusion and Outlook; References; 5 CNS Inflammation; 5.1 Introduction; 5.2 The Pathologic Characteristics of the MS Plaque; 5.3 Axonal Pathology in MS; 5.4 Neuronal Pathology in Multiple Sclerosis; 5.5 Lessons from Animal Models; References; 6 Neurotrauma; 6.1 Introduction; 6.2 In Vivo Models; 6.2.1 Static Brain Injury Models; 6.2.2 Dynamic Brain Injury Models; 6.2.2.1 Indirect Dynamic Brain Injury; 6.2.2.2 Direct Dynamic Brain Injury 6.2.3 Combined Neurotrauma Models |
| Record Nr. | UNINA-9910877851903321 |
| Weinheim, : Wiley-VCH, c2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||